Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment

J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.03.022. Epub 2022 Mar 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Alanine / analogs & derivatives
  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Dexamethasone / therapeutic use
  • Humans
  • SARS-CoV-2*

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Dexamethasone
  • Alanine